Validation | Jotup

Akeneo Named Overall Ventana Research Value Index Leader in Product eXperience Management Research

Retrieved on:

Tuesday, April 18, 2023

The independent market research ranked Akeneo first overall in Customer Experience and second place in Product Experience

Key Points:

Boston, Massachusetts--(Newsfile Corp. - April 18, 2023) - Akeneo , the product experience company, is pleased to announce that it has been recognized by Ventana Research , an independent market research and technology advisory services firm, as a Value Index Leader in the 2023 Product Experience Management (PXM) Value Index .
The PXM Value Index is a measure of a vendor's ability to fulfill a buyer's PXM needs using their software.
This quantitative, research-based index assessed Akeneo and 15 other PIM vendors across seven categories, comprising five Product Experience categories and two Customer Experience categories: Adaptability, Capability, Manageability, Reliability, and Usability were related to product experience, while Validation and TCO/ROI pertained to customer experience.
"Congratulations to Akeneo for its overall Value Index Leader ranking in our 2023 Product eXperience Value Index and the continued investment to its platform and portfolio of products necessary for organizations and its commitment to the Customer Experience it provides," said Mark Smith, CEO and Chief Research Officer at Ventana Research.

Gotransverse Ranks as “Exemplary Vendor” in Ventana Research Subscription Management Value Index for 2023

Retrieved on:

Tuesday, April 18, 2023

Omni, Validation, Telecommunications, API, ERP, Ziply Fiber, Organization, Total cost, Ventana, Risk, CRM, Usability, TCO, Research, Online shopping, Cryptocurrency, Telstra, Index, Newtel Solutions

AUSTIN, Texas, April 18, 2023 (GLOBE NEWSWIRE) -- Gotransverse ( www.gotransverse.com ), the leading provider of enterprise order-to-cash solutions, today announced that the Gotransverse intelligent billing platform has ranked as an Exemplary Vendor in the Ventana Research Subscription Management Value Index for 2023.

Key Points:

AUSTIN, Texas, April 18, 2023 (GLOBE NEWSWIRE) -- Gotransverse ( www.gotransverse.com ), the leading provider of enterprise order-to-cash solutions, today announced that the Gotransverse intelligent billing platform has ranked as an Exemplary Vendor in the Ventana Research Subscription Management Value Index for 2023.
“Gotransverse consistently ranged in the upper middle range of our evaluation,” according to the Ventana Research report.
Ventana Research’s latest Subscription Management Value Index gave us high marks for adaptability and product experience, and we are striving to continually add value in other areas.
The Subscription Management Value Index is the most comprehensive report of such application vendors.”
For more information about the Ventana Research Value Index, visit https://www.ventanaresearch.com/value_index/office_of_revenue/subscripti... .

Base Carbon Reports Year End 2022 Operating and Financial Results

Retrieved on:

Friday, March 31, 2023

TORONTO, March 31, 2023 (GLOBE NEWSWIRE) -- Base Carbon Inc. (NEO: BCBN) (OTCQX: BCBNF) (“Base Carbon”, or the “Company”) is pleased to announce its year-end 2022 consolidated financial results and operational highlights.

Key Points:

TORONTO, March 31, 2023 (GLOBE NEWSWIRE) -- Base Carbon Inc. (NEO: BCBN) (OTCQX: BCBNF) (“Base Carbon”, or the “Company”) is pleased to announce its year-end 2022 consolidated financial results and operational highlights.
Blue Carbon Partnership with Danish Red Cross: In Q4 2022, Base Carbon signed a letter of intent with the Danish Red Cross to develop blue carbon projects in Southeast Asia, with the scope including a potential mangrove carbon credit removal project.
“2022 was transformational for Base Carbon where we established a foundation to grow our business.
Base Carbon and Hardwick Climate Business Limited (“HCBL”) have mutually agreed not to complete the proposed 100% acquisition of HCBL by Base Carbon.

Newly Published Study Demonstrates the Clinical Effectiveness of Machine Learning Used to Achieve Remission in Patients with Peanut Allergies

Retrieved on:

Wednesday, April 5, 2023

The paper, titled “ Food Anaphylaxis Diagnostic Marker Compilation in Machine Learning Design and Validation ,” co-authored with data scientists Kirill Groshenkovand Grigori Sigalov, is the first peer-reviewed study to analyze the role and effectiveness of machine learning in actively treating patients with severe food allergies.

Key Points:

The paper, titled “ Food Anaphylaxis Diagnostic Marker Compilation in Machine Learning Design and Validation ,” co-authored with data scientists Kirill Groshenkovand Grigori Sigalov, is the first peer-reviewed study to analyze the role and effectiveness of machine learning in actively treating patients with severe food allergies.
“The treatment technique used, the Tolerance Induction Program (TIP), is a clinical therapeutics model steeped in data science and innovations in machine learning to treat patients with severe food allergies.
"We now have over a decade plus of machine learning and AI experience,” said Dr. Randhawa.
And leave the program with what we call ‘food freedom’ – free of their previously deadly food allergies – all thanks to constantly evolving machine learning."

HealthSparq Launches New Solution to Address Provider Data Accuracy for a Better Consumer Experience

Retrieved on:

Tuesday, April 4, 2023

HealthSparq , a Kyruus company, unveiled Validated Provider Profiles to help health plans meet federal and state provider data requirements and improve the accuracy of member-facing directories.

Key Points:

HealthSparq , a Kyruus company, unveiled Validated Provider Profiles to help health plans meet federal and state provider data requirements and improve the accuracy of member-facing directories.
As many as half of provider directories have inaccurate data, causing health plans to face citations and fines.
With Validated Provider Profiles, health plans can automate data collection and ongoing validation to improve care access for members.
It offers health plans the ability to:
To learn more about HealthSparq Validated Provider Profiles, click here .

Cenlar Promotes Leaders across the Organization

Retrieved on:

Thursday, March 30, 2023

“On behalf of the entire Cenlar team, I would like to congratulate all of these exceptional leaders on their promotions and look forward to their continued success and contributions to the company.”

Key Points:

“On behalf of the entire Cenlar team, I would like to congratulate all of these exceptional leaders on their promotions and look forward to their continued success and contributions to the company.”
William “Bill” Benefield, to Director, Contact Center.
Bill assists with the oversight of the default contact center and its employees in the in the O’Fallon, MO location.
Prior to Cenlar, Bill held various leadership roles at Citibank for more than 17 years.
He began his career at Cenlar 15 years ago in the Treasury department where he managed Cenlar’s portfolio of non-agency mortgage backed securities.

Rare Event Analysis in Flow Cytometry: Design Control and Validation Aligned with CLSI H62, Upcoming Webinar Hosted by Xtalks

Retrieved on:

Wednesday, March 15, 2023

CD34, Research, Drug discovery, Drug development, MRD, CLSI, Design controls, Cell, CAR, PNH, Validation, Cytokine, Clinical Laboratory, Clinical trial, Flow cytometry, Doctor of Philosophy, Bone marrow, Bureau of Oceans and International Environmental and Scientific Affairs, Medical device

TORONTO, March 15, 2023 /PRNewswire-PRWeb/ -- Rare event analysis by flow cytometry is relatively common in research settings, in clinical laboratories and during drug discovery and development. For example, in research and drug discovery environments, the measurement of intracellular cytokines and intracellular signaling events (i.e., protein phosphorylation) are some of the more common rare event assays. Whereas in clinical laboratories, assays for rare events often include the measurement of CD34+ hematopoietic stem cells, paroxysmal nocturnal hemoglobinuria (PNH) and minimal residual disease (MRD) of blood cancers. During drug development and clinical trial evaluation of new therapeutic modalities, rare event methods might also include the monitoring of CAR cellular therapies and the efficacy of cell-depleting therapies.

Key Points:

In this free webinar, learn about rare event analysis in flow cytometry using design control and validation approaches aligned with CLSI H62.
Attendees will learn how the application of Design Control during assay design and development will lead to successful outcomes.
Attendees will learn impact of instrument set-up, panel design and assay optimization on the validation of the assay specificity and sensitivity.
Register today and learn about rare event analysis in flow cytometry using design control and validation approaches aligned with CLSI H62.

Gotion High-Tech Wins Volkswagen Cell Test Lab Qualification

Retrieved on:

Thursday, February 23, 2023

Volkswagen Group, Validation, CSA, Carbon, Volkswagen Group China, Safety, Volkswagen, Cell, CCS, CNAS, Olaf, Environment, TUV, Certification, Medical device

HONG KONG, Feb 23, 2023 - (ACN Newswire) - On February 21, Gotion High-tech was officially granted the Volkswagen Cell Test Lab qualification certificate.

Key Points:

HONG KONG, Feb 23, 2023 - (ACN Newswire) - On February 21, Gotion High-tech was officially granted the Volkswagen Cell Test Lab qualification certificate.
This certification marks the recognition of Gotion's test capability by Volkswagen and its formal entry into the world-leading technological management system.
Chairman of Gotion High-Tech, Li Zhen(right six, front row).
Director of Gotion High-Tech, Executive Vice President of VW Group China, Frank Engel( right seven, front row).

Automobili Pininfarina: Battista Hyper GT Continues Record-Breaking Spree in India

Retrieved on:

Thursday, February 23, 2023

Exciting short films showcasing the achievements may be seen here: https://youtu.be/GWuZ5YruhF8

Key Points:

Exciting short films showcasing the achievements may be seen here: https://youtu.be/GWuZ5YruhF8
The Battista top speed test was undertaken with Michelin Pilot Sport Cup 2 tyres fitted.
Paolo Dellachà, Automobili Pininfarina CEO said: "We were very proud to bring Battista to India for the first time.
"For Hormazd and his Autocar India team to showcase what is possible with Battista in their hands is hugely important.
A unique livery adorns the beautiful, exposed carbonfibre body of the Battista tested in India, crafted by Automobili Pininfarina's talented Colour, Materials and Finishes Design team.

AUTOMOBILI PININFARINA: BALLISTIC BATTISTA CONTINUES RECORD-BREAKING SPREE IN INDIA

Retrieved on:

Thursday, February 23, 2023

Exciting short films showcasing the achievements may be seen here: https://youtu.be/GWuZ5YruhF8

Key Points:

Exciting short films showcasing the achievements may be seen here: https://youtu.be/GWuZ5YruhF8
The Battista top speed test was undertaken with Michelin Pilot Sport Cup 2 tyres fitted.
Paolo Dellachà, Automobili Pininfarina CEO said: "We were very proud to bring Battista to India for the first time.
"For Hormazd and his Autocar India team to showcase what is possible with Battista in their hands is hugely important.
A unique livery adorns the beautiful, exposed carbonfibre body of the Battista tested in India, crafted by Automobili Pininfarina's talented Colour, Materials and Finishes Design team.